Figure 2.

Administration of MetfDeca showing a lowering in blood glucose levels of hyperglycemic rats. The animals (n = 10/group) were administered with this compound at doses (0.7, 1.4, 2.5, 5, and 10 μM) for 4 weeks in rats with alloxan-induced hyperglycemia (150 mg/kg). The graph shows the percentage of animals with reduced levels of glucose.